.
GSK Consumer Healthcare to merge with Hindustan Unilever
GSK Consumer Healthcare to merge with Hindustan Unilever

Photo Credit: India-consumer.GSK

IANS

Mumbai, Dec 3 (IANS) FMCG major Hindustan Unilever on Monday said it will merge GlaxoSmithKline Consumer Healthcare Ltd with itself for an all equity transaction worth Rs 31,700 crore.

The deal would bring the brand of Horlicks, a malted-milk, in Hindustan Unilever's portfolio.

As per the deal, GSK Consumer's shareholders would get 4.39 shares of Hindustan Unilever's shares for each share they held in GSK consumer Healthcare, a regulatory filing by Hindustan Unilever said.

The company said: "We will drive significant cost synergies from a combination of supply chain efficiencies and operational improvements, go-to-market and distribution network optimisation, scale in a number of cost areas such as marketing and streamlining of overlapping infrastructure."

Commenting on the merger, Sanjiv Mehta, Chairman and Managing Director, Hindustan Unilever said: "The turnover of our F&R (food and refreshment) business will exceed Rs 100 billion (10,000 crore ) and we will become one of the largest F&R businesses in the country."

Following the issue of new Hindustan Unilever shares, Unilever's holding in the company will be diluted from 67.2 per cent to 61.9 per cent.

The merger includes the totality of operations within GSK Consumer Healthcare India, including a consignment selling contract to distribute GSK CH India's Over-the-Counter and oral health products in India.

The transaction is expected to be completed in one year subject to regulatory and shareholder approvals.

The announcement of the merger lifted the stock price of both the companies. Shares of Hindustan Unilever closed at Rs 1,825.90 apiece, up Rs 72.30 or 4.12 per cent from the previous close.

Similarly, shares of GSK Consumer Healthcare settled 3.75 per cent or Rs 272.90 higher at Rs 7,542.85 per share.

 

© 2018 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.

For news, views and gossips, follow @IANSLIVE at Twitter. Find us on Facebook too!

Update: 03-December-2018

RELATED TOPICS

BUSINESS



© 2018 IANS India Private Limited.
Don't forget to bookmark us! (CTRL-D)
Site designed by IANS